Answer
No interaction studies have been performed with idecabtagene vicleucel; co-administration with agents that inhibit T-cell function has not been formally studied, and co-administration with agents that stimulate T-cell function has not been investigated and its effects are unknown.
Sources for this answer
- Abecma 260 - 500 x 10^6 cells dispersion for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 3Document updated
Sources checked